NCT06892535View on ClinicalTrials.gov

Low-dose Albumin Infusion for the Prevention of Paracentesis Induced Circulatory Dysfunction (PICD), After Large Volume Paracentesis (LVP) in Decompensated Cirrhosis Liver.

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Paracentesis-Induced Circulatory Dysfunction
Interventions
DRUG

Albumin infusion, 2g/L of ascitic fluid aspiration.

Albumin infusion lower than the standard dose, either 2g/L or 4g/L of ascitic fluid aspiration is termed as low dose.

Trial Locations (1)

1000

Department of Hepatology, Bangabandhu Sheikh Mujib Medical University. Dhaka, Bangladesh., Dhaka

All Listed Sponsors
lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER

NCT06892535 - Low-dose Albumin Infusion for the Prevention of Paracentesis Induced Circulatory Dysfunction (PICD), After Large Volume Paracentesis (LVP) in Decompensated Cirrhosis Liver. | Biotech Hunter | Biotech Hunter